Alimta ANDA Products Hit Double Digits With Several Launches
Fresenius Kabi Has ‘Broadest Portfolio Available’
Following patent expiry on 24 May, Alimta ANDA products have reached the US market, eating into a product that generated more than $1.2bn in sales last year.
